Page last updated: 2024-11-05

sintamil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

sintamil: has pronounced sedative properties, but otherwise resembles imipramine; minor descriptor (77-84); on-line & Index Medicus search DIBENZOXAZEPINES (77-84); RN given refers to mono-HCl [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12195997
MeSH IDM0262778

Synonyms (22)

Synonym
sintamil
16398-39-3
dibenz(b,f)(1,4)oxazepin-11(10h)-one, 10-(3-(dimethylamino)propyl)-2-nitro-, monohydrochloride
nitroxazepine hydrochloride
10-(3-(dimethylamino)propyl)-2-nitrodibenz(b,f)(1,4)oxazepin-11(10h)-one monohydrochloride
einecs 240-449-1
ciba 2330-go
10-(3-(dimethylamino)propyl)-2-nitrobenz(b,f)(1,4)oxazepin-11(10h)-one hydrochloride
unii-y7lu3bj31l
y7lu3bj31l ,
ciba-2330-go
nitroxazepine hydrochloride [who-dd]
10-(3-(dimethylamino)propyl)-2-nitro-dibenz(b,f)(1,4)oxazepin-11(10h)-one monohydrochloride
ciba-2330go
dibenz(b,f)(1,4)oxazepin-11(10h)-one, 10-(3-(dimethylamino)propyl)-2-nitro-, hydrochloride (1:1)
10-[3-(dimethylamino)propyl]-2-nitrodibenz[b,f][1,4]oxazepin-11(10h)-one monohydrochloride
dimethyl-[3-(8-nitro-6-oxobenzo[b][1,4]benzoxazepin-5-yl)propyl]azaniumchloride
DTXSID00936895
10-[3-(dimethylamino)propyl]-2-nitrodibenzo[b,f][1,4]oxazepin-11(10h)-one--hydrogen chloride (1/1)
5-[3-(dimethylamino)propyl]-8-nitrobenzo[b][1,4]benzoxazepin-6-one;hydrochloride
Q27294354
10-(3-(dimethylamino)propyl)-2-nitrodibenzo[b,f][1,4]oxazepin-11(10h)-one hydrochloride
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (87.50)18.7374
1990's1 (12.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (11.11%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (11.11%)4.05%
Observational0 (0.00%)0.25%
Other7 (77.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]